Cargando…

Impact of circulating tumor DNA in hepatocellular and pancreatic carcinomas

Hepatocellular carcinoma (HCC) and pancreatic cancer (PC) belong to the most lethal malignancies worldwide. Despite advances in surgical techniques and perioperative multidisciplinary management, the prognosis of both carcinoma entities remains poor mainly because of rapid tumor progression and earl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dhayat, Sameer A., Yang, Zixuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Review – Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256092/ https://www.ncbi.nlm.nih.gov/pubmed/32338295 http://dx.doi.org/10.1007/s00432-020-03219-5

Ejemplares similares

Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma
por: Dhayat, Sameer A., et al.
Publicado: (2015)

Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma
por: Flammang, Isabelle, et al.
Publicado: (2020)

Preoperative evaluation of microvascular invasion with circulating tumour DNA in operable hepatocellular carcinoma
por: Wang, Dong, et al.
Publicado: (2020)

Potential of Exosomal microRNA-200b as Liquid Biopsy Marker in Pancreatic Ductal Adenocarcinoma
por: Reese, Moritz, et al.
Publicado: (2020)

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Ye, Qianwei, et al.
Publicado: (2019)

Using Tumor-Informed Circulating Tumor DNA (ctDNA)-Based Testing for Patients with Anal Squamous Cell Carcinoma
por: Azzi, Georges, et al.
Publicado: (2022)

Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: A systematic review and meta‐analysis
por: Zhang, Ziying, et al.
Publicado: (2019)

Circulating tumor DNA in hepatocellular carcinoma: trends and challenges
por: Tang, Jia-Cheng, et al.
Publicado: (2016)

Genetics of Hepatocellular Carcinoma: From Tumor to Circulating DNA
por: Campani, Claudia, et al.
Publicado: (2023)

Small extracellular vesicle non-coding RNAs in pancreatic cancer: molecular mechanisms and clinical implications
por: Reese, Moritz, et al.
Publicado: (2021)

Circulating Tumor DNA in Patients with Renal Cell Carcinoma. A Systematic Review of the Literature
por: Geertsen, Louise, et al.
Publicado: (2022)

Circulating tumor cells detected with a microcavity array predict clinical outcome in hepatocellular carcinoma
por: Takahashi, Kazuto, et al.
Publicado: (2021)

Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Li, Jie, et al.
Publicado: (2018)

Apatinib targets both tumor and endothelial cells in hepatocellular carcinoma
por: Yang, Chaoxu, et al.
Publicado: (2018)

Impact of the COVID-19 pandemic on patients with hepatocellular carcinoma in the West of Scotland: a cohort study
por: McLaren, Alistair Stewart, et al.
Publicado: (2023)

Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic Cancer
por: Gao, Yang, et al.
Publicado: (2016)

Targetting an LncRNA P5848-ENO1 axis inhibits tumor growth in hepatocellular carcinoma
por: Zhu, Xidan, et al.
Publicado: (2019)

Circulating proteins and risk of pancreatic cancer: a case-subcohort study among Chinese adults
por: Kartsonaki, Christiana, et al.
Publicado: (2022)

Predictors of hepatic decompensation after TACE for hepatocellular carcinoma
por: Kohla, Mohamed A S, et al.
Publicado: (2015)

Commentary on: Nomograms based on inflammatory biomarkers for predicting tumor grade and microvascular invasion in stage I/II hepatocellular carcinoma
por: Xiao, Liang, et al.
Publicado: (2019)

Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma
por: Ge, Zhouhong, et al.
Publicado: (2021)

Current progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma
por: Yin, Xiaoqiang, et al.
Publicado: (2022)

Liquid Biopsy Using Cell-Free or Circulating Tumor DNA in the Management of Hepatocellular Carcinoma
por: Lyu, Xueying, et al.
Publicado: (2022)

Dynamic Changes in Circulating Tumor DNA During Chemoradiation for Locally Advanced Lung Cancer
por: Corradetti, Michael N., et al.
Publicado: (2019)

Clusterin role in hepatocellular carcinoma patients treated with oxaliplatin
por: Wang, Xiumei, et al.
Publicado: (2020)

Inflammatory processes involved in NASH-related hepatocellular carcinoma
por: Cannito, Stefania, et al.
Publicado: (2023)

Prognostic value of aberrantly expressed methylation genes in human hepatocellular carcinoma
por: Zhen, Limin, et al.
Publicado: (2020)

Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinoma
por: Xia, Yujia, et al.
Publicado: (2021)

Role of circulating tumor DNA to help decision-making in hepatocellular carcinoma
por: von Felden, Johann, et al.
Publicado: (2018)

Circulating Tumor Cells Measurements in Hepatocellular Carcinoma
por: Chiappini, Franck
Publicado: (2012)

Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence
por: Shi, Ji‐Hua, et al.
Publicado: (2019)

Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma
por: Vithayathil, Mathew, et al.
Publicado: (2022)

Research progress on circulating tumor cells of hepatocellular carcinoma
por: Wan, Chenyu, et al.
Publicado: (2021)

Development and validation of a nomogram for assessing survival in patients with hepatocellular carcinoma after hepatectomy
por: Huo, Rong-Rui, et al.
Publicado: (2020)

Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases
por: Seeberg, Lars Thomas, et al.
Publicado: (2017)

Post surgery circulating free tumor DNA is a predictive biomarker for relapse of lung cancer
por: Hu, Wenwei, et al.
Publicado: (2017)

The power of tumor sizes in predicting the survival of solitary hepatocellular carcinoma patients
por: Yang, Anli, et al.
Publicado: (2018)

A hypoxia-related prognostic model predicts overall survival and treatment response in hepatocellular carcinoma
por: Xing, Jiyuan, et al.
Publicado: (2022)

Probing of breast cancer using a combination of plasma and urinary circulating cell-free DNA
por: Zuo, Zhigang, et al.
Publicado: (2020)

Statin use and the prognosis of patients with hepatocellular carcinoma: a meta-analysis
por: Li, Xiaofei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eh6a8tu8s0ifcjkin1gru69vpp